Asset Allocation

As of November 30, 2025.
Type % Net
Cash 2.13%
Stock 69.41%
Bond 28.90%
Convertible 0.00%
Preferred 0.00%
Other -0.44%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 42.23%
Mid 22.27%
Small 35.50%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 93.58%    % Emerging Markets: 6.15%    % Unidentified Markets: 0.26%

Americas 54.99%
51.20%
Canada 2.66%
United States 48.53%
3.79%
Mexico 3.79%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 36.87%
United Kingdom 15.48%
19.51%
Austria 2.23%
France 7.18%
Germany 0.74%
Netherlands 4.03%
Spain 5.34%
0.00%
1.88%
Israel 1.88%
Greater Asia 7.87%
Japan 3.18%
0.00%
2.34%
Hong Kong 2.34%
2.36%
India 2.36%
Unidentified Region 0.26%

Bond Credit Quality Exposure

AAA 0.00%
AA 4.30%
A 7.11%
BBB 37.42%
BB 29.00%
B 17.21%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 4.95%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
25.78%
Materials
3.22%
Consumer Discretionary
17.78%
Financials
4.78%
Real Estate
0.00%
Sensitive
51.48%
Communication Services
14.37%
Energy
0.00%
Industrials
14.16%
Information Technology
22.96%
Defensive
22.74%
Consumer Staples
6.92%
Health Care
15.82%
Utilities
0.00%
Not Classified
0.00%
Non Classified Equity
0.00%
Not Classified - Non Equity
0.00%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 4.30%
Corporate 95.70%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
2.21%
Less than 1 Year
2.21%
Intermediate
92.87%
1 to 3 Years
40.64%
3 to 5 Years
29.59%
5 to 10 Years
22.65%
Long Term
4.92%
10 to 20 Years
4.92%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial